glp 1 pancreatic cancer risk GLP-1 Agonists and Pancreatitis Risk: Reassessing an Old Concern with New Evidence Studies examining GLP-1 RA therapy

This side effect occurs as your body adjusts to the medication, which works to regulate appetite and blood sugar levels

Patients with diabetic retinopathy should report any vision changes, as rapid improvement in blood glucose can temporarily worsen retinopathy, particularly with semaglutide

This combination therapy may optimize disease management, particularly in patients with severe, refractory HS or those with significant metabolic comorbidities

Multiple drugs within this class have been approved for T2D management since the mid-2000s

Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review

Performing this confirmatory, Elashoff-like analysis (Fig